Dogwood Therapeutics, Inc. (DWTX) Advances SP16 Program with FDA Investigational New Drug Approval
TheFly reported on April 15 that DWTX announced that the U.S.
Dogwood Therapeutics Inc. (DWTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 3,280,000 | $6,920,800 | 0.12% | |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 11,756 | $24,805 | +1% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.30 | 15,335 | $19,992.24 | 52,045 | 2023-08-21 | Filing | |
| $1.25 | 25,000 | $31,245.00 | 57,461 | 2023-08-17 | Filing | |
| $4.58 | 2,000 | $9,150.00 | 3,000 | 2022-05-23 | Filing | |
| $4.52 | 7,500 | $33,900.00 | 32,461 | 2022-05-23 | Filing | |
| $4.53 | 500 | $2,262.50 | 2,500 | 2022-05-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.26 | 1,800 | $466.38 | 700 | 2022-12-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 132,154 | $278,845 | 0% | |
| 2. | 79,434 | $167,608 | 0% | |
| 3. | 62,736 | $132,373 | 0% | |
| 4. | 23,779 | $50,174 | 0% | |
| 5. | 14,598 | $30,802 | 0% |
News See All
8 Oversold Biotech Stocks to Invest In Now
On February 5, J.P. Morgan revealed major themes that are expected to affect healthcare in 2026, emphasizing a resurgence of interest in the biopharma sector.
Hedge Fund Resource Center